Precision medicine in rare tumors and the need for multicenter trials and international collaboratives: Sinonasal cancer as paradigm

Affiliations

¹ Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University of Brescia, ASST-Spedali Civili, Brescia, Italy. Electronic address: paolo.bossi@unibs.it.
² Department of Head and Neck Oncology, Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
³ UCL Cancer Institute, University College London, London, UK.
⁴ Department of Translational Research and of New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Paolo Bossi et al. Oral Oncol. 2020 Oct.

. 2020 Oct:109:104737.

doi: 10.1016/j.oraloncology.2020.104737. Epub 2020 Apr 25.

¹ Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University of Brescia, ASST-Spedali Civili, Brescia, Italy. Electronic address: paolo.bossi@unibs.it.
² Department of Head and Neck Oncology, Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
³ UCL Cancer Institute, University College London, London, UK.
⁴ Department of Translational Research and of New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

No abstract available

Conflict of interest statement

Declaration of Competing Interest The authors declared that there is no conflict of interest.